LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Moderna Inc

Open

SectorGezondheidszorg

26.03 4.88

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

24.82

Max

26.17

Belangrijke statistieken

By Trading Economics

Inkomsten

149M

-971M

Verkoop

-859M

107M

K/W

Sectorgemiddelde

35.86

56.602

EPS

-2.52

Winstmarge

-907.477

Werknemers

5,800

EBITDA

194M

-924M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+86.2% upside

Dividenden

By Dow Jones

Volgende Winsten

31 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2.7B

9.9B

Vorige openingsprijs

21.15

Vorige sluitingsprijs

26.03

Nieuwssentiment

By Acuity

100%

0%

367 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Moderna Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 mrt 2025, 14:19 UTC

Belangrijke Marktbewegers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb 2025, 18:52 UTC

Belangrijke Marktbewegers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

15 nov 2024, 10:28 UTC

Belangrijke Marktbewegers

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

12 mei 2025, 22:14 UTC

Top Nieuws

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 mei 2025, 18:45 UTC

Top Nieuws

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

12 mei 2025, 17:14 UTC

Top Nieuws

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- WSJ

28 apr 2025, 17:04 UTC

Winsten

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

28 feb 2025, 12:00 UTC

Top Nieuws

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

24 feb 2025, 10:17 UTC

Populaire aandelen

Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba -- WSJ

14 feb 2025, 22:04 UTC

Winsten

These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 feb 2025, 20:26 UTC

Winsten

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 feb 2025, 17:34 UTC

Winsten

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14 feb 2025, 15:42 UTC

Winsten

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DraftKings, GameStop, and More -- Barrons.com

14 feb 2025, 14:02 UTC

Top Nieuws
Winsten

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. -- Barrons.com

14 feb 2025, 11:38 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:34 UTC

Winsten

These Stocks Are Moving the Most Today: Intel, Airbnb, DraftKings, GameStop, Moderna, Roku, Palo Alto, and More -- Barrons.com

14 feb 2025, 11:30 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

4 feb 2025, 19:34 UTC

Top Nieuws

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 feb 2025, 18:51 UTC

Top Nieuws

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

21 jan 2025, 10:12 UTC

Populaire aandelen

Stocks to Watch Tuesday: MicroStrategy, Trump Media, Moderna, Ørsted -- WSJ

13 jan 2025, 13:51 UTC

Winsten

Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. -- Barrons.com

8 jan 2025, 09:43 UTC

Populaire aandelen

Stocks to Watch Wednesday: Moderna, Nvidia, Albertsons, Flutter -- WSJ

15 nov 2024, 19:24 UTC

Winsten

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15 nov 2024, 17:23 UTC

Winsten

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15 nov 2024, 15:43 UTC

Winsten

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Alibaba, Bloom Energy, and More -- Barrons.com

15 nov 2024, 13:34 UTC

Top Nieuws

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov 2024, 13:08 UTC

Top Nieuws

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15 nov 2024, 11:14 UTC

Marktinformatie

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

15 nov 2024, 10:34 UTC

Marktinformatie

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

7 nov 2024, 11:53 UTC

Top Nieuws
Winsten

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

Peer Vergelijking

Prijswijziging

Moderna Inc Prognose

Koersdoel

By TipRanks

86.2% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 46.29 USD  86.2%

Hoogste 212 USD

Laagste 21 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Moderna Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

19 ratings

4

Buy

12

Hold

3

Sell

Technische score

By Trading Central

23.7 / 27.88Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

367 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.